These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 22589186)

  • 1. Proteomic identification of E6AP as a molecular target of tamoxifen in MCF7 cells.
    Lochab S; Pal P; Kanaujiya JK; Tripathi SB; Kapoor I; Bhatt ML; Sanyal S; Behre G; Trivedi AK
    Proteomics; 2012 May; 12(9):1363-77. PubMed ID: 22589186
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Keratinocyte growth factor (KGF) induces tamoxifen (Tam) resistance in human breast cancer MCF-7 cells.
    Chang HL; Sugimoto Y; Liu S; Ye W; Wang LS; Huang YW; Lin YC
    Anticancer Res; 2006; 26(3A):1773-84. PubMed ID: 16827106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Solid lipid nanoparticles: Reversal of tamoxifen resistance in breast cancer.
    Guney Eskiler G; Cecener G; Dikmen G; Egeli U; Tunca B
    Eur J Pharm Sci; 2018 Jul; 120():73-88. PubMed ID: 29719240
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigation of elemene-induced reversal of tamoxifen resistance in MCF-7 cells through oestrogen receptor α (ERα) re-expression.
    Zhang B; Zhang X; Tang B; Zheng P; Zhang Y
    Breast Cancer Res Treat; 2012 Nov; 136(2):399-406. PubMed ID: 23053650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative profiling of drug-associated proteomic alterations by combined 2-nitrobenzenesulfenyl chloride (NBS) isotope labeling and 2DE/MS identification.
    Ou K; Kesuma D; Ganesan K; Yu K; Soon SY; Lee SY; Goh XP; Hooi M; Chen W; Jikuya H; Ichikawa T; Kuyama H; Matsuo E; Nishimura O; Tan P
    J Proteome Res; 2006 Sep; 5(9):2194-206. PubMed ID: 16944931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estrogen receptor-α variant, ER-α36, is involved in tamoxifen resistance and estrogen hypersensitivity.
    Zhang X; Wang ZY
    Endocrinology; 2013 Jun; 154(6):1990-8. PubMed ID: 23546601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hesperidin, piperine and bee venom synergistically potentiate the anticancer effect of tamoxifen against breast cancer cells.
    Khamis AAA; Ali EMM; El-Moneim MAA; Abd-Alhaseeb MM; El-Magd MA; Salim EI
    Biomed Pharmacother; 2018 Sep; 105():1335-1343. PubMed ID: 30021371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A naringenin-tamoxifen combination impairs cell proliferation and survival of MCF-7 breast cancer cells.
    Hatkevich T; Ramos J; Santos-Sanchez I; Patel YM
    Exp Cell Res; 2014 Oct; 327(2):331-9. PubMed ID: 24881818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreased chicken ovalbumin upstream promoter transcription factor II expression in tamoxifen-resistant breast cancer cells.
    Riggs KA; Wickramasinghe NS; Cochrum RK; Watts MB; Klinge CM
    Cancer Res; 2006 Oct; 66(20):10188-98. PubMed ID: 17047084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. COX-2 silencing enhances tamoxifen antitumor activity in breast cancer in vivo and in vitro.
    Du Y; Shi A; Han B; Li S; Wu D; Jia H; Zheng C; Ren L; Fan Z
    Int J Oncol; 2014 Apr; 44(4):1385-93. PubMed ID: 24535190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of Sirtuin 3, a mitochondrial protein deacetylase, as a new contributor to tamoxifen resistance in breast cancer cells.
    Zhang L; Ren X; Cheng Y; Huber-Keener K; Liu X; Zhang Y; Yuan YS; Yang JW; Liu CG; Yang JM
    Biochem Pharmacol; 2013 Sep; 86(6):726-33. PubMed ID: 23856293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proyl isomerase Pin1 facilitates ubiquitin-mediated degradation of cyclin-dependent kinase 10 to induce tamoxifen resistance in breast cancer cells.
    Khanal P; Yun HJ; Lim SC; Ahn SG; Yoon HE; Kang KW; Hong R; Choi HS
    Oncogene; 2012 Aug; 31(34):3845-56. PubMed ID: 22158035
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term treatment with tamoxifen facilitates translocation of estrogen receptor alpha out of the nucleus and enhances its interaction with EGFR in MCF-7 breast cancer cells.
    Fan P; Wang J; Santen RJ; Yue W
    Cancer Res; 2007 Feb; 67(3):1352-60. PubMed ID: 17283173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tamoxifen-induced activation of p21Waf1/Cip1 gene transcription is mediated by Early Growth Response-1 protein through the JNK and p38 MAP kinase/Elk-1 cascades in MDA-MB-361 breast carcinoma cells.
    Kim CG; Choi BH; Son SW; Yi SJ; Shin SY; Lee YH
    Cell Signal; 2007 Jun; 19(6):1290-300. PubMed ID: 17307334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dietary flaxseed interaction with tamoxifen induced tumor regression in athymic mice with MCF-7 xenografts by downregulating the expression of estrogen related gene products and signal transduction pathways.
    Chen J; Power KA; Mann J; Cheng A; Thompson LU
    Nutr Cancer; 2007; 58(2):162-70. PubMed ID: 17640162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isolated and combined action of tamoxifen and metformin in wild-type, tamoxifen-resistant, and estrogen-deprived MCF-7 cells.
    Berstein LM; Yue W; Wang JP; Santen RJ
    Breast Cancer Res Treat; 2011 Jul; 128(1):109-17. PubMed ID: 20683653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential response to phytoestrogens in endocrine sensitive and resistant breast cancer cells in vitro.
    Limer JL; Parkes AT; Speirs V
    Int J Cancer; 2006 Aug; 119(3):515-21. PubMed ID: 16506217
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Berberine enhances the anti‑tumor activity of tamoxifen in drug‑sensitive MCF‑7 and drug‑resistant MCF‑7/TAM cells.
    Wen C; Wu L; Fu L; Zhang X; Zhou H
    Mol Med Rep; 2016 Sep; 14(3):2250-6. PubMed ID: 27432642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of proliferation of estrogen receptor‑positive MCF‑7 human breast cancer cells by tamoxifen through c‑Jun transcription factors.
    Xu Y; Zou ST; Zhu R; Li W; Gu CW; Wei SH; Xie JM; Wu HR
    Mol Med Rep; 2013 Apr; 7(4):1283-7. PubMed ID: 23404426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. E6AP, an E3 ubiquitin ligase negatively regulates granulopoiesis by targeting transcription factor C/EBPα for ubiquitin-mediated proteasome degradation.
    Pal P; Lochab S; Kanaujiya JK; Kapoor I; Sanyal S; Behre G; Trivedi AK
    Cell Death Dis; 2013 Apr; 4(4):e590. PubMed ID: 23598402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.